Newsroom


Please note that the Company does not update, correct or revise news releases after they have been issued. For the most current information about the Company, please refer to the most recent releases.

4/22/2019, Monday

Media Contact:
Kristy Marks
Kristy.marks@bausch.com
(908) 927-0683

Teresa Panas
teresa@tgpcomm.com  
(973) 809-8590
 

BAUSCH + LOMB TO INITIATE SERIES OF U.S. CLINICAL TRIALS FOR TECHNOLAS® TENEO™ EXCIMER LASER

BRIDGEWATER, N.J., Apr. 22, 2019 – Bausch + Lomb, a global eye health company, today announced it will initiate a series of U.S. clinical trials to evaluate the safety and efficacy of Technolas® Teneo™ excimer laser for vision correction surgery for myopia and myopic astigmatism. The company expects the clinical trials to begin by July 2019.

“The global LASIK market continues to grow, and the Technolas Teneo laser, which has a compact footprint, has been well received and widely adopted in more than 50 countries,” said Chuck Hess, vice president and general manager, U.S. Surgical, Bausch + Lomb. “Our plan to initiate a series of clinical trials, and ultimately pursue regulatory approval for this technology in the United States, is part of our commitment providing surgeons with a full suite of innovations to meet the needs of their patients.”

The system being studied will be the same as the Technolas Teneo laser (model 2) currently being sold outside the United States. Bausch + Lomb plans to file for premarket approval (PMA) of the Technolas Teneo laser from the U.S. Food & Drug Administration (FDA) at the conclusion of the clinical trials.

About Bausch + Lomb
Bausch + Lomb, a division of Bausch Health Companies, is a leading global eye health organization that is solely focused on helping people see better to live better. Its core businesses include over-the-counter products, dietary supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care products, and ophthalmic surgical devices and instruments. Bausch + Lomb develops, manufactures and markets one of the most comprehensive product portfolios in the industry, which is available in more than 100 countries. For more information, visit www.bausch.com.

###

®/™ are trademarks of Bausch & Lomb Incorporated or its affiliates.
Any other product/brand names are trademarks of the respective owners.
© 2019 Bausch & Lomb Incorporated. 
TET.0014.USA.19

Print

Number of views (893)/Comments (0)

x